Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-04

Clinical Trial Update: Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique [NA]

View source ↗

Summary

Changping Laboratory is evaluating neuromodulation at different doses to treat treatment-resistant depression using a pBFS-guided approach; recruitment is ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Changping Laboratory | Conditions: Moderate Depression, Major Depressive Disorder | NA | Status: RECRUITING